Nicholas Galakatos, Director at Ophthotech Corp. (OPHT), sold 3,000 shares at $58.69 ($178K) on 2015-11-10, disclosed to the SEC on 2015-11-12.
Scheduled sale ($178k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 500 | $30K | 16.9% |
| 2 | $60.00 | 1,000 | $60K | 33.7% |
| 3 | $58.69 | 500 | $29K | 16.5% |
| 4 | $58.69 | 1,000 | $59K | 33.0% |
| Total | $59.34 avg | 3,000 | $178K | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |